Effect of Tacrolimus vs Intravenous Cyclophosphamide on Complete or Partial Response in Patients With Lupus Nephritis: A Randomized Clinical Trial

IMPORTANCE: Lupus nephritis (LN) is typically treated with intravenous cyclophosphamide (IVCY), which is associated with serious adverse effects. Tacrolimus may be an alternative for initial treatment of LN; however, large-scale, randomized clinical studies of tacrolimus are lacking. OBJECTIVE: To a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Zhaohui, Zhang, Haitao, Peng, Xiaomei, Zhang, Chun, Xing, Changying, Xu, Gang, Fu, Ping, Ni, Zhaohui, Chen, Jianghua, Xu, Zhonggao, Zhao, Ming-hui, Li, Shaomei, Huang, Xiangyang, Miao, Lining, Chen, Xiaonong, Liu, Bicheng, He, Yongcheng, Li, Jing, Liu, Lijun, Kadeerbai, Haishan, Liu, Zhangsuo, Liu, Zhihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969066/
https://www.ncbi.nlm.nih.gov/pubmed/35353167
http://dx.doi.org/10.1001/jamanetworkopen.2022.4492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969066/
https://www.ncbi.nlm.nih.gov/pubmed/35353167
http://dx.doi.org/10.1001/jamanetworkopen.2022.4492

Ejemplares similares